Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly Janes(Fred Hutch Cancer Center), M. Juliana McElrath(Fred Hutch Cancer Center), Kristen W. Cohen(Moderna Therapeutics (United States)), Douglas I. Grove(Fred Hutch Cancer Center), Richard A. Koup(Aaron Diamond AIDS Research Center), Barney S. Graham(National Institutes of Health), Chuka Anude(National Institute of Allergy and Infectious Diseases), Susan Buchbinder(University of California, San Francisco), Craig A. Magaret(Fred Hutch Cancer Center), Nicole Frahm(Fred Hutch Cancer Center), Carter Bentley(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lawrence Corey(Fred Hutch Cancer Center), Beryl A. Koblin(New York Blood Center), Mark J. Mulligan(New York University), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Greg Finak(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brittany Sanchez(Fred Hutch Cancer Center), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Magdalena E. Sobieszczyk(Columbia University Irving Medical Center), Elizabeth M. Adams(National Institutes of Health), Stephen C. De Rosa(University of Washington), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Scott M. Hammer, Raphaël Gottardo(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael C. Keefer(University of Rochester Medical Center), Mingchao Shen(Fred Hutch Cancer Center)
Cited by 75
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k